fig3
![Imaging after liver-directed therapy: evidenced-based update of the LI-RADS treatment response algorithm](https://image.oaes.cc/a9bc2024-1268-4876-ae63-60f0e0cf80e9/5744.fig.3.jpg)
Figure 3. 68-year-old female with chronic HBV presenting with a large LR 5 observation showing APHE (A) and washout (B). Arterial phase MRI 1 month after TACE shows no intralesional enhancement and a smooth perilesional rim of enhancement without masslike areas of enhancement (C).